Drugs for Treatment of Constipation-Predominant IBS
Prescription, Nonprescription and Orphan Drugs
Drug Administration and Therapy Phases: Overview
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Diarrhea-Predominant IBS
Drug Regulation
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Updated: Jul 28, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
Sean Duggan1, Zaina T Al-Salama2
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. dru@adis.com.
莱尼奥利西布是一种选择性氨酸体3 - 激酶-三角酶抑制剂,现在已被批准用于激活PI3Kδ综合征 (APDS). 这标志着治疗这种罕见的免疫缺陷障碍的重要里程碑.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: